[Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung cancer].
Tissue characterization is a major and ultimate goal of imaging, whether morphological (Computed Tomography, Magnetic Resonance Imaging) or metabolic (PET-FDG-[18F]). Functional imaging, using the MRI, began several years ago with the perfusion of lung nodules and very recently with diffusion-weighted imaging applied to the lung cancer. The authors review the interest and the place of diffusion-weighted and perfusion MR imaging in the diagnosis, early staging and follow-up of patients with lung cancer.
Khalil
A
A
Service de radiologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France. antoine.khalil@tnn.aphp.fr
Thomassin-Naggara
I
I
Gounant
V
V
Nedelcu
N
N
Marsault
C
C
Carette
M-F
MF
D003287:Contrast Media / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply* / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009367:Neoplasm Staging
D003287:Contrast Media